A woman hemorrhages after delivery. The hospital has the medication to stop it. The nurse follows the protocol. She dies anyway, because the protocol was not practiced, the team was not drilled, and the risk was not flagged on admission. That is a quality failure. Now put that same woman in rural Pennsylvania, 90 minutes from the nearest obstetric unit. She never makes it to the protocol. That is an access failure. The United States is producing both deaths, at scale, and has been for decades.
The Joint Commission launched outcomes-driven perinatal care certifications on April 3, 2026, citing that US maternal mortality rates have doubled since 1987 despite medical advances, with over 80% of deaths preventable. The American Hospital Association and Epic launched a postpartum hemorrhage collaborative on April 1, targeting the cause behind 14% of maternal deaths per the latest CDC data. Pennsylvania's Shapiro administration released a $12.3 million maternal health plan addressing rural care deserts and postpartum screening gaps. All of this activity is welcome. None of it resolves the underlying policy confusion about what, exactly, we are solving.
The False Dichotomy That Protects No One
When researchers and administrators say maternal mortality is preventable through "improved access to, and quality of, health care," that phrasing is doing a lot of political work. It is accurate. It is also a way to avoid prioritizing. Funding a hospital's hemorrhage simulation training does nothing for a patient who cannot reach the hospital. Expanding rural maternity coverage does nothing if the facility she reaches has no standardized PPH response. These are not competing theories. They are sequential failures in the same patient's trajectory.
The racial data makes this concrete. In Pennsylvania, Black mothers died from pregnancy-related causes at twice the rate of white mothers as of 2021, per the state's Maternal Mortality Review Committee. Black women in Pennsylvania are not uniformly rural. Many live in Philadelphia and Pittsburgh, cities with major academic medical centers. The access argument alone cannot explain a 2x mortality gap inside a city with hospitals on every major corridor. That gap is a quality problem: undertreated pain, dismissed symptoms, protocols applied inconsistently by race. The access argument is not wrong; it is incomplete, and using it as the primary frame lets urban hospitals off the hook.
What the Evidence Actually Supports
I will grant the access advocates one fair point: maternity care deserts are real, and no amount of protocol improvement helps a patient who delivers in a car. Rural expansion must happen. But the evidence from Pennsylvania's own 16-roundtable review process shows that behavioral health integration, workforce diversity, and care coordination failures are driving deaths in places where access technically exists. Those are quality and systems problems, not geography problems.
The Joint Commission's new certification framework is the most structurally honest response I have seen: it evaluates hospitals on actual outcomes, not on whether they have a policy document filed somewhere. That is the right instrument. The AHA's eight-month PPH collaborative is a reasonable pilot. Pennsylvania's $7.5 million budget proposal for 2026-27 is a start, though modest against the scale of the problem.
What I want from Congress and from CMS, whose ACCESS model launches in July 2026, is a refusal to let states report process metrics as outcomes. Screening rates are not survival rates. The 80% preventability figure is not a reassurance. It is an indictment. Every year we spend debating the framing is a year we spend confirming it.
